| 5.23 Data as of Jun 19 |  +0.15 / +2.95%Today’s Change | 4.71 Today|||52-Week Range 6.80 | +0.77% Year-to-Date |
| StreetInsider.com Pre-Open Movers 6/19: (PLX) (CYTK) (ADBE) Higher; (OSH) (VNDA) (TTE... Jun 19 / Investing Channel | American Generics Can't Touch This $8 Billion Drug (Yet) Jun 17 / MotleyFool.com |
| StreetInsider.com Pre-Open Movers 6/19: (PLX) (CYTK) (ADBE) Higher; (OSH) (VNDA) (TTE... Jun 19 / Investing Channel |
| Previous close | 5.08 |
| Today’s open | 5.35 |
| Day’s range | -- - -- |
| Volume | 1,310,048 |
| Average volume (3 months) | 174,915 |
| Market cap | $475.0M |
| Dividend yield | -- |
| Earnings growth (last year) | +69.77% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +25.00% |
| Revenue growth (last year) | +1,059.84% |
| P/E ratio | NM |
| Price/Sales | 13.70 |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| HPTXHyperion Therapeutic... | +0.09 | +0.44% |
| OSIROsiris Therapeutics ... | -0.16 | -1.50% |
| KMDAKamada Ltd | -0.24 | -2.20% |
| NVAXNovavax Inc | -0.04 | -2.07% |
| Next reporting date | August 28, 2013 |
| EPS forecast (this quarter) | -$0.04 |
| Annual revenue (last year) | $34.4M |
| Annual profit (last year) | -$11.6M |
| Net profit margin | -33.75% |
Sector Health Services |
Industry Services to the Health Industry |
President, Chief Executive Officer & Director David Aviezer, PhD, MBA |
Chief Operating Officer Tzvi Palash |
Corporate headquarters Carmiel, -- |
.
